DiagnoCure
Healthcare Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4535 Wilfrid-hamel Blvd Ste 250, Quebec,...Phone Number
(418) 527-6100Website
www.diagnocure.comRevenue
<$5 MillionIndustry
About DiagnoCure
Is DiagnoCure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
DiagnoCure, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if DiagnoCure had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at DiagnoCure
Check if DiagnoCure has recently received funding, and reach out quickly before it becomes old news!
Check out if DiagnoCure is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once DiagnoCure has new funding data
Product Launch: Get notified when DiagnoCure launches new products
Earning: See what the market has to say on DiagnoCure recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined DiagnoCure as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
DiagnoCure is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
DiagnoCure is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about DiagnoCure.
DiagnoCure Tech Stack
A closer look at the technologies used by DiagnoCure
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding DiagnoCure
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and provides molecular and genomic tests to support effective clinical decisions enabling personalized medicine in oncology. Previstage® GCC and the Corporation new multimarker prostate cancer test are currently available for licensing. The Corporation has granted a wo... Read More